Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEFERASIROX Cause Breakthrough haemolysis? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Breakthrough haemolysis have been filed in association with DEFERASIROX (Deferasirox). This represents 0.0% of all adverse event reports for DEFERASIROX.

5
Reports of Breakthrough haemolysis with DEFERASIROX
0.0%
of all DEFERASIROX reports
0
Deaths
4
Hospitalizations

How Dangerous Is Breakthrough haemolysis From DEFERASIROX?

Of the 5 reports, 4 (80.0%) required hospitalization.

Is Breakthrough haemolysis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEFERASIROX. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does DEFERASIROX Cause?

Death (1,583) Diarrhoea (993) Serum ferritin increased (732) Haemoglobin decreased (615) Pyrexia (607) Malaise (605) Nausea (603) Sickle cell anaemia with crisis (570) Vomiting (520) Pneumonia (494)

What Other Drugs Cause Breakthrough haemolysis?

RAVULIZUMAB-CWVZ (120) ECULIZUMAB (100) PEGCETACOPLAN (67) IPTACOPAN (22) DANICOPAN (8)

Which DEFERASIROX Alternatives Have Lower Breakthrough haemolysis Risk?

DEFERASIROX vs DEFERIPRONE DEFERASIROX vs DEFEROXAMINE DEFERASIROX vs DEFIBROTIDE DEFERASIROX vs DEFLAZACORT DEFERASIROX vs DEGARELIX

Related Pages

DEFERASIROX Full Profile All Breakthrough haemolysis Reports All Drugs Causing Breakthrough haemolysis DEFERASIROX Demographics